Oxidative stress hypothesis in Alzheimer's disease.
暂无分享,去创建一个
[1] H. Kappus,et al. Cellular toxicity and lipid peroxidation in response to mercury. , 1982, Toxicology and applied pharmacology.
[2] W. Markesbery,et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[3] P. Oteiza. A mechanism for the stimulatory effect of aluminum on iron-induced lipid peroxidation. , 1994, Archives of biochemistry and biophysics.
[4] W. D. Ehmann,et al. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.
[5] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[6] M. Albert,et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.
[7] S. Rapoport,et al. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. , 1994, Brain research. Molecular brain research.
[8] Z. Pan,et al. Role of Nerve Growth Factor in Oxidanl Homeostasis: Glutathione Metabolism , 1993, Journal of neurochemistry.
[9] C. Gottfries,et al. Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II) , 1994, Journal of neurochemistry.
[10] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[11] G. Mckhann,et al. Diseases of the Nervous System: Clinical Neurobiology , 1992 .
[12] T. Montine,et al. E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. , 1996, The American journal of pathology.
[13] J. Parks,et al. Spin trapping of azidyl and hydroxyl radicals in azide-inhibited rat brain submitochondrial particles. , 1994, Archives of biochemistry and biophysics.
[14] P. Mecocci,et al. Oxidative damage to mitochondrial DNA shows marked age‐dependent increases in human brain , 1993, Annals of neurology.
[15] R N Kalaria,et al. Induction of Heme Oxygenase‐1 mRNA and Protein in Neocortex and Cerebral Vessels in Alzheimer's Disease , 1995, Journal of neurochemistry.
[16] G. Reynolds,et al. Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations. , 1985, JAMA.
[17] B. Weiss,et al. Food additives as a source of behavioral disturbances in children. , 1986, Neurotoxicology.
[18] S. Wolff,et al. Oxidative glycation and free radical production: a causal mechanism of diabetic complications. , 1991, Free radical research communications.
[19] D. Wallace,et al. Diseases of the mitochondrial DNA. , 1992, Annual review of biochemistry.
[20] C. Marsden,et al. Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.
[21] A. M. Saunders,et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.
[22] J. Rommens,et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.
[23] J. Hazel,et al. The role of alterations in membrane lipid composition in enabling physiological adaptation of organisms to their physical environment. , 1990, Progress in lipid research.
[24] M. Brammer,et al. Brain membrane fluidity and lipid peroxidation in Alzheimer's disease , 1990, Neuroscience Letters.
[25] G. Schellenberg,et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.
[26] A. Prochiantz,et al. Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[27] A. Stern,et al. Mechanism of Kainate Toxicity to Cerebellar Neurons In Vitro Is Analogous to Reperfusion Tissue Injury , 1987, Journal of neurochemistry.
[28] A. Alzheimer. Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .
[29] B. Halliwell,et al. Free radicals in biology and medicine , 1985 .
[30] M. Golub,et al. Effects of aluminum on brain lipid peroxidation. , 1990, Toxicology letters.
[31] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[32] C. Marsden,et al. LIPID PEROXIDATION AS CAUSE OF NIGRAL CELL DEATH IN PARKINSON'S DISEASE , 1986, The Lancet.
[33] W. D. Ehmann,et al. Regional brain trace-element studies in Alzheimer's disease. , 1988, Neurotoxicology.
[34] O. Pastoris,et al. The mitochondrial electron transfer alteration as a factor involved in the brain aging , 1992, Neurobiology of Aging.
[35] V. Monnier,et al. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. , 1981, Science.
[36] C. Behl,et al. Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.
[37] D. Borchelt,et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.
[38] M. Verity. Mechanisms of Phospholipase A2 Activation and Neuronal Injury , 1993, Annals of the New York Academy of Sciences.
[39] D. Miller,et al. Effects of ceruloplasmin on superoxide-dependent iron release from ferritin and lipid peroxidation. , 1991, Free radical research communications.
[40] M. Mattson. Calcium and Free Radicals: Mediators of neurotrophic factor and excitatory transmitter-regulated developmental plasticity and cell death. , 1996, Perspectives on developmental neurobiology.
[41] G. Jackson,et al. Role of nerve growth factor in oxidant‐antioxidant balance and neuronal injury. I. Stimulation of hydrogen peroxide resistance , 1990, Journal of neuroscience research.
[42] D. McLachlan,et al. Intramuscular desferrioxamine in patients with Alzheimer's disease , 1991, The Lancet.
[43] G. Perry,et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Mattson,et al. β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease , 1994 .
[45] R. Katzman.,et al. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa , 1980, Nature.
[46] J. Coyle,et al. Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.
[47] D. Price,et al. Age‐Dependent Impairment of Mitochondrial Function in Primate Brain , 1993, Journal of neurochemistry.
[48] M. Mattson,et al. PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: evidence for induction of antioxidant pathways , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[49] C. W. Scott,et al. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[50] Z. Khachaturian. Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.
[51] V. Monnier,et al. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. , 1989, The Journal of biological chemistry.
[52] G E Gibson,et al. Aging and the brain , 1994, Current opinion in neurology.
[53] W. Whetsell. Current Concepts of Excitotoxicity , 1996, Journal of neuropathology and experimental neurology.
[54] H. Reichmann,et al. Electron transport chain defects in Alzheimer's disease. , 1994, Neurology.
[55] M. Mattson,et al. A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide , 1997, Journal of neurochemistry.
[56] H. Feldman,et al. Serum levels of the iron binding protein p97 are elevated in Alzheimer′s disease , 1996, Nature Medicine.
[57] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.
[58] C. Olanow. A radical hypothesis for neurodegeneration , 1993, Trends in Neurosciences.
[59] M. Shelanski,et al. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[60] R. Katzman.,et al. Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. , 1976, Archives of neurology.
[61] W. Jefferies,et al. Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin , 1996, Brain Research.
[62] R. Bartus,et al. The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.
[63] Patrizia Mecocci,et al. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.
[64] Peters Ll. DRUG TREATMENT IN PSYCHIATRY. , 1964 .
[65] M. Mattson,et al. Secreted Forms of β-Amyloid Precursor Protein Protect Hippocampal Neurons against Amyloid β-Peptide-Induced Oxidative Injury , 1994, Experimental Neurology.
[66] W. D. Ehmann,et al. Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease , 1994, Neuroscience Letters.
[67] F. Buonanno,et al. In Vitro31P NMR Spectroscopy Detects Altered Phospholipid Metabolism in Alzheimer's Disease , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[68] D R Wekstein,et al. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. , 1996, JAMA.
[69] M. Mattson,et al. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation , 1994, Brain Research.
[70] D. Butterfield,et al. Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.
[71] S. Kish,et al. Brain glutathione peroxidase in neurodegenerative disorders. , 1986, Neurochemical pathology.
[72] J. Klinowski,et al. Aluminosilicate-lnduced Free Radical Generation by Murine Brain Glial Cells in vitro: Potential Significance in the Aetiopathogenesis of Alzheimer's Dementia , 1992 .
[73] M. Mattson,et al. Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[74] B. Hyman,et al. Functional Alterations in Alzheimer's Disease: Selective Loss of Mitochondrial-encoded Cytochrome Oxidase mRNA in the Hippocampal Formation , 1994, Journal of neuropathology and experimental neurology.
[75] C. Cotman,et al. Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation. , 1991, Neuroreport.
[76] D. Pollen,et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.
[77] M. Beal,et al. Oxidative damage in Alzheimer's , 1996, Nature.
[78] D. Perl,et al. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study , 1992, Annals of neurology.
[79] W. D. Ehmann,et al. Brain trace elements in Alzheimer's disease. , 1986, Neurotoxicology.
[80] M. Mattson,et al. Neurotrophic Factors Attenuate Glutamate‐Induced Accumulation of Peroxides, Elevation of Intracellular Ca2+ Concentration, and Neurotoxicity and Increase Antioxidant Enzyme Activities in Hippocampal Neurons , 1995, Journal of neurochemistry.
[81] R. Nixon,et al. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[82] M. Beal,et al. Aging, energy, and oxidative stress in neurodegenerative diseases , 1995, Annals of neurology.
[83] J. Parks,et al. Cytochrome C Oxidase in Alzheimer's Disease Brain , 1995, Neurology.
[84] M. Folstein,et al. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease , 1995, Neurology.
[85] L. Ang,et al. Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro , 1990, Journal of neurochemistry.
[86] B. Halliwell. Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? , 1989, Acta neurologica Scandinavica. Supplementum.
[87] W. D. Ehmann,et al. Brain aluminum in Alzheimer's disease using an improved GFAAS method. , 1992, Neurotoxicology.
[88] C. Masters,et al. The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I) , 1996, Science.
[89] A. Carpenter,et al. Morphometric Analysis of Microglia in Alzheimer's Disease , 1993, Journal of neuropathology and experimental neurology.
[90] W. D. Ehmann,et al. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress , 1996, Journal of the Neurological Sciences.
[91] G. Perry,et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. , 1994, The American journal of pathology.
[92] L. Goodman. Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. , 1953, The Journal of nervous and mental disease.
[93] W. R. Brain. Diseases of the Nervous System , 1892, Buffalo Medical and Surgical Journal.
[94] W. D. Ehmann,et al. Elemental imbalances in the olfactory pathway in Alzheimer's disease , 1995, Journal of the Neurological Sciences.
[95] J. Growdon,et al. Evidence for a membrane defect in Alzheimer disease brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[96] M. Beal,et al. Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease , 1994, Journal of neurochemistry.
[97] K. Beyreuther,et al. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. , 1992, The Journal of biological chemistry.
[98] A. D. Roses,et al. Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .
[99] J. McCord,et al. Oxygen-derived free radicals in postischemic tissue injury. , 1985, The New England journal of medicine.
[100] S. Hoyer. Brain Oxidative Energy and Related Metabolism, Neuronal Stress, and Alzheimer's Disease: A Speculative Synthesis , 1993, Journal of geriatric psychiatry and neurology.
[101] M. Mullan,et al. β-Amyloid-mediated vasoactivity and vascular endothelial damage , 1996, Nature.
[102] D. Butterfield,et al. Direct evidence of oxidative injury produced by the Alzheimer's β-Amyloid peptide (1–40) in cultured hippocampal neurons , 1995, Experimental Neurology.
[103] D. Dickson,et al. Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. , 1988, The American journal of pathology.
[104] D. Bredesen,et al. Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.
[105] J. Connor,et al. Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions , 1995, Journal of neurochemistry.
[106] Joseph Loscalzo,et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds , 1993, Nature.
[107] A. Novelli,et al. Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced , 1988, Brain Research.
[108] A. Palmer,et al. Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease , 1994, Brain Research.
[109] M. Mattson,et al. Neurotrophic factor mediated protection from excitotoxicity and disturbances in calcium and free radical metabolism , 1993 .
[110] D. Perl,et al. Evidence of neuronal oxidative damage in Alzheimer's disease. , 1996, The American journal of pathology.
[111] R. Bucala,et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[112] M. Mattson,et al. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[113] W. D. Ehmann,et al. Elevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s Disease , 1997, Neurobiology of Aging.
[114] E. Uemura,et al. Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ , 1995, Brain Research.
[115] D. Butterfield,et al. Electron paramagnetic resonance investigations of free radical-induced alterations in neocortical synaptosomal membrane protein infrastructure. , 1994, Free radical biology & medicine.
[116] D. Kirschner,et al. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.
[117] J. Pettegrew,et al. 31P Nuclear Magnetic Resonance Study of the Brain in Alzheimer's Disease , 1988, Journal of neuropathology and experimental neurology.
[118] B. Winblad,et al. Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type , 1985, Journal of the Neurological Sciences.
[119] M. Pericak-Vance,et al. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs , 1995, Neurobiology of Aging.
[120] C. Cotman,et al. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage , 1990, Brain Research.
[121] A. Henderson,et al. The epidemiology of Alzheimer's disease. , 1986, British medical bulletin.
[122] M. Mattson,et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[123] D. Salmon,et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education , 1990, Annals of neurology.
[124] D. D. Cowell. Senile Dementia of the Alzheimer's Type , 1983 .
[125] J. Richardson. Free Radicals in the Genesis of Alzheimer's Disease a , 1993, Annals of the New York Academy of Sciences.
[126] K. Jellinger,et al. Decreased Catalase Activity but Unchanged Superoxide Dismutase Activity in Brains of Patients with Dementia of Alzheimer Type , 1995, Journal of neurochemistry.
[127] E. Stopa,et al. Expression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain , 1995, Annals of neurology.
[128] G. Benzi,et al. Age-related modifications of cytochrome c oxidase activity in discrete brain regions , 1990, Mechanisms of Ageing and Development.
[129] J. Connor,et al. Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease , 1993, Neuroscience Letters.
[130] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[131] P. Chagnon,et al. Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. , 1995, Neuroreport.
[132] Ferritin: isolation of aluminum-ferritin complex from brain. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[133] J. Nobrega,et al. Brain Cytochrome Oxidase in Alzheimer's Disease , 1992, Journal of neurochemistry.
[134] B. Yankner,et al. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro , 1995, Nature.
[135] S. Lipton,et al. Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.
[136] N. Robakis,et al. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease , 1992 .
[137] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[138] M. Beal,et al. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.
[139] B T Hyman,et al. Functional Alterations in Alzheimer's Disease: Diminution of Cytochrome Oxidase in the Hippocampal Formation , 1993, Journal of neuropathology and experimental neurology.
[140] T. Montine,et al. Crosslinking of Apolipoprotein E by Products of Lipid Peroxidation , 1996, Journal of neuropathology and experimental neurology.
[141] B. Halliwell,et al. Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts. , 1985, Biochimica et biophysica acta.
[142] F. V. van Kuijk,et al. 4-hydroxynonenal inhibits Na(+)-K(+)-ATPase. , 1996, Free radical biology & medicine.
[143] D. Neary,et al. Presynaptic Serotonergic Dysfunction in Patients with Alzheimer's Disease , 1987, Journal of neurochemistry.
[144] W. D. Ehmann,et al. Neutron activation analysis of trace elements in motor neuron disease spinal cord. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.